Included In This Lesson
Outline
What is the Generic Name
BRINZOLAMIDE/BRIMONIDINE TARTRATE
What is the Trade Name for BRINZOLAMIDE/BRIMONIDINE TARTRATE
SIMBRINZA
What is the Indication for BRINZOLAMIDE/BRIMONIDINE TARTRATE
- 1 INDICATIONS AND USAGE SIMBRINZA (brinzolamide and brimonidine tartrate ophthalmic suspension) 1% and 0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. SIMBRINZA is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources